Concept information
Preferred term
Cetuximab
Type
-
Topical Descriptor
Broader concept
Entry terms
- Erbitux
- IMC C225
Scope note
- A chimeric monoclonal antibody that functions as an ANTINEOPLASTIC AGENT through its binding to the EPIDERMAL GROWTH FACTOR RECEPTOR, where it prevents the binding and signaling action of cell growth and survival factors.
History note
- 2016 (2000)
In other languages
-
Finnish
-
Swedish
-
Erbitux
URI
http://www.yso.fi/onto/mesh/D000068818
{{label}}
{{#each values }} {{! loop through ConceptPropertyValue objects }}
{{#if prefLabel }}
{{/if}}
{{/each}}
{{#if notation }}{{ notation }} {{/if}}{{ prefLabel }}
{{#ifDifferentLabelLang lang }} ({{ lang }}){{/ifDifferentLabelLang}}
{{#if vocabName }}
{{ vocabName }}
{{/if}}